SCHEMBL8083393

SCHEMBL8083393

CCCCN1CCC(O)(c2ccc(OC)cc2)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.59
ALDH1A1 P00352 1/20 0.59
LMNA P02545 1/20 0.59
KMT2A Q03164 1/20 0.59
SLC6A1 P30531 1/20 0.57
SLC6A12 P48065 1/20 0.57
SLC6A11 P48066 1/20 0.57
CCR1 P32246 3/20 0.52
MMP9 P14780 1/20 0.48
MMP13 P45452 1/20 0.48
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47
OPRK1 P41145 1/20 0.47
OPRL1 P41146 1/20 0.47
DRD2 P14416 3/20 0.46
DRD3 P35462 3/20 0.46
DRD4 P21917 1/20 0.46
SIGMAR1 Q99720 2/20 0.45
HTR1A P08908 1/20 0.44
DRD1 P21728 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8071002 0.86 ALDH1A1 (0.54) MEN1ALDH1A1LMNAKMT2ASLC6A1
SCHEMBL8080898 0.83 DRD2 (0.60) CCR1DRD2DRD3DRD4HTR1A
SCHEMBL8081750 0.83 DRD2 (0.50) MEN1ALDH1A1LMNAKMT2ACCR1
SCHEMBL8080268 0.78 OPRM1 (0.55) MEN1ALDH1A1LMNAKMT2ASLC6A1
SCHEMBL3114214 0.77 DRD2 (0.48) LMNAKMT2ADRD2DRD3DRD4
SCHEMBL3115631 0.77 DRD2 (0.53) KMT2ACCR1OPRM1OPRD1OPRK1
SCHEMBL3109586 0.75 DRD2 (0.46) LMNAOPRM1OPRL1DRD2DRD3
SCHEMBL3111256 0.75 DRD2 (0.49) CCR1DRD2DRD3DRD4HTR1A
SCHEMBL1103890 0.75 OPRM1 (0.61) MEN1ALDH1A1LMNAKMT2ASLC6A1
SCHEMBL3118433 0.74 DRD2 (0.48) OPRM1OPRD1OPRK1OPRL1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155671-B1 DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION INTEGRATIVE RES LABORATORIES SWEDEN AB (SE) 2017-12-20 EP disclosed
US-8188301-B2 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2012-05-29 US disclosed
US-8188301-B2 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2012-05-29 US disclosed
US-20100179211-A1 DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB (DK) 2010-07-15 US disclosed
US-20100179211-A1 DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB (DK) 2010-07-15 US disclosed
WO-2008148801-A2 DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION NSAB, FILIAL OF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179211-A1 DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION PNMT, DBH, SLC6A2 MEN1 2078/4885ALDH1A1 1996/4885LMNA 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.